01 August 2005
Cerebrospinal fluid tumor marker levels in predicting response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.Christos Kosmas, Nicolas B Tsavaris, George Tsakonas, Georgia Soukouli, Argyris Gassiamis, Nicolas Mylonakis, Athanasios Karabelis
Med Sci Monit 2005; 11(8): CR398-401 :: ID: 202098
Background: The aim of this study was to evaluate the predictive valueof cerebrospinal fluid (CSF) tumor marker levels in patients with breast cancer and carcinomatous meningitis.Material/Methods: Serial CSF and serum tumor marker (CEA, CA-15.3, CA-125, and CA-19.9) measurementswere performed in five patients with breast cancer developing carcinomatous meningitis in an attemptto correlate these with clinical outcome under treatment. Results: CSF tumor marker levels correlatedwith response to treatment and outcome in each patient; despite achieving negative CSF cytology aftertherapy, in two patients it heralded disease progression. Conclusions: Given our findings, CSF tumormarker evaluation may provide a reliable means and surrogate end-points of monitoring response of carcinomatousmeningitis to treatment. Therefore, large studies to assess the value of CSF tumor marker changes incarcinomatous meningitis are warranted.
Keywords: Breast Neoplasms - cerebrospinal fluid, Tumor Markers, Biological - cerebrospinal fluid, Breast Neoplasms - therapy, Meningeal Neoplasms - therapy, Meningitis - therapy, Neoplasm Staging, Predictive Value of Tests, Survival Rate, Tumor Markers, Biological - cerebrospinal fluid
01 December 2022 : EditorialEditorial: The World Health Organization (WHO) Fungal Priority Pathogens List in Response to Emerging Fungal Pathogens During the COVID-19 Pandemic
Med Sci Monit 2022; 28:e939088
29 November 2022 : Clinical ResearchRetrospective Study to Identify Risk Factors for Severe Disease and Mortality Using the Modified Early Warn...
Med Sci Monit In Press; DOI: 10.12659/MSM.938647
07 December 2022 : Clinical ResearchA Prospective Questionnaire-Based Study to Evaluate Factors Affecting the Decision to Receive COVID-19 Vacc...
Med Sci Monit 2022; 28:e938665
01 December 2022 : EditorialEditorial: The World Health Organization (WHO) Fungal Priority Pathogens List in Response to Emerging Funga...
Med Sci Monit 2022; 28:e939088
07 Dec 2022 : Review articleA Review of the Ethical Use of Animals in Functional Experimental Research in China Based on the “Four R” P...
Med Sci Monit In Press; DOI: 10.12659/MSM.938807
07 Dec 2022 : Meta-AnalysisPrevalence of Burnout in Healthcare Specialties: A Systematic Review Using Copenhagen and Maslach Burnout I...
Med Sci Monit In Press; DOI: 10.12659/MSM.938798
05 Dec 2022 : Database AnalysisImpact of the De Ritis Ratio on the Prognosis of Patients with Stable Coronary Artery Disease Undergoing Pe...
Med Sci Monit In Press; DOI: 10.12659/MSM.937737
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
01 Nov 2020 : Review articleLong-Term Respiratory and Neurological Sequelae of COVID-19
Med Sci Monit 2020; 26:e928996